Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Old drugs give new hope in cancer
Wednesday 3 August 2022, 12:05 AM

Cancer-drug study doctor David Young with Gillies McIndoe Research Institute director Swee Tan and study coordinator Ruth Watson-Black – phase II trial is ready to launch once funding is finalised [image: Supplied]
Virginia McMillan follows up on the cancer-drug trial she first reported in 2017, when patients with glioblastoma were being recruited to test a regimen of repurposed drugs
The 17 patients in an internationally novel clinical trial run from Hutt Valley did not live to see the promising results of the drug regimen they we
References
O’Rawe M, Wickremesekera A, Pandey R et al. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. J Clin Neurosci 2022;95:48–54.